We are live on
!
Find out more
MCM
Mengis Capital Management Portfolio holdings
AUM
$658M
1-Year Est. Return
39.64%
This Fund
S&P 500
This Quarter
Est. Return
+17.95%
1 Year Est. Return
+39.64%
3 Year Est. Return
+91.78%
5 Year Est. Return
+129.93%
10 Year Est. Return
+407.15%
AUM
$337M
AUM Growth
+$44M
(+15%)
Cap. Flow
-$2.63M
Cap. Flow
% of AUM
-0.78%
Top 10 Holdings %
Top 10 Hldgs %
37.16%
Holding
162
New
3
Increased
55
Reduced
58
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$741K |
| 2 |
Merck
MRK
|
+$540K |
| 3 |
iShares Gold Trust
IAU
|
+$346K |
| 4 |
JPMorgan Chase
JPM
|
+$269K |
| 5 |
Vanguard Dividend Appreciation ETF
VIG
|
+$268K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.15M |
| 2 |
Prudential Financial
PRU
|
+$866K |
| 3 |
Advanced Micro Devices
AMD
|
+$570K |
| 4 |
AGN
Allergan plc
AGN
|
+$521K |
| 5 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
+$453K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 17.43% |
| 3 | Industrials | 15.19% |
| 4 | Consumer Staples | 8.47% |
| 5 | Financials | 5.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QEP
151
DELISTED
QEP RESOURCES, INC.
QEP
| $32K | 0.01% |
25,000
| – | – |
|
152
Alaska Air
ALK
$5.6B
| – | – |
-10,360
| Closed | -$294K |
|
153
First Trust Preferred Securities and Income ETF
FPE
$6.34B
| – | – |
-10,117
| Closed | -$165K |
|
154
Hexcel
HXL
$7.73B
| – | – |
-8,150
| Closed | -$303K |
|
|
MMP
155
DELISTED
Magellan Midstream Partners, L.P.
MMP
| – | – |
-5,900
| Closed | -$215K |
|
|
RDS.A
156
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| – | – |
-6,201
| Closed | -$216K |
|
|
AGN
157
DELISTED
Allergan plc
AGN
| – | – |
-2,946
| Closed | -$521K |
|
|
JPM.PRH
158
DELISTED
JPMorgan Chase & Co.
JPM.PRH
| – | – |
-11,350
| Closed | -$285K |
|
Similar funds
VCM
PIM
CG
CAM
BL
DAS
UCMOK
ACM
Mengis Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Mengis Capital Management held 162 positions worth $337M, up 15% from $293M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Mengis Capital Management's Q2 2020 filing shows 3 new, 55 increased, 58 reduced and 7 closed positions. Its largest new stake was Vanguard Dividend Appreciation ETF: 2,353 shares worth $275K. The largest sale was Schwab Short-Term US Treasury ETF, an estimated $1.15M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.
- Mengis Capital Management's largest Q2 2020 buy was Vanguard Dividend Appreciation ETF: 2,353 shares worth $275K.
- Mengis Capital Management added most to Bristol-Myers Squibb in Q2 2020, an estimated $741K increase.
- Mengis Capital Management's biggest Q2 2020 reduction was Schwab Short-Term US Treasury ETF, cutting an estimated $1.15M.
- Mengis Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $521K.
- Mengis Capital Management's ten largest holdings make up 37% of its $337M portfolio in Q2 2020.
- Mengis Capital Management opened 3 new positions and closed 7 in Q2 2020.
- Mengis Capital Management's portfolio value rose 15% quarter-over-quarter to $337M.
Based on Mengis Capital Management's 13F filing for Q2 2020, filed 22 Jul 2020.